Shabbir Dahod, CEO of our portfolio company, TraceLink, recently joined CNBC’s Worldwide Exchange to discuss the process of securing the supply chain for the Covid-19 vaccine rollout.
TraceLink has been involved in securing the pharmaceutical supply chain for over a decade, and Shabbir has extensive knowledge of the challenges that will arise as various COVID-19 vaccines begin to disseminate.
In fact, TraceLink has built the largest track and trace network in the world for pharmaceutical drugs, with over 280,000 entities, which gives it tremendous insight into this process.
